Advanced Sperm Selection Techniques and Their Contribution to Blastocyst Euploidy Rates

NCT ID: NCT05494216

Last Updated: 2024-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

515 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-01

Study Completion Date

2024-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparing different advanced sperm selection techniques like Physiological ICSI (PICSI) and magnetic activated cell sorting (MACS) in terms of the PGT-A outcomes of each arm blastocysts

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Advanced sperm selection methods like PICSI and MACS have been developed for selecting a healthy mature non apoptotic sperm with lower Sperm DNA fragmentation. Previous studies compared the pre-implantation embryo development parameters of those techniques, but none looked at comparing the PGT-A results or euploidy rates of the blastocysts derived from each sperm selection.

PGT-A cases will be randomized on the day of ICSI to the 2 assigned sperm selection techniques.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sperm DNA Fragmentation Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PICSI

Semen processing is done by double layer density gradient method followed by adding Sperm to the dot of hyaluronan on the PICSI dish, within minutes the bound sperm are attached by their acrosome to the surface of the dot. Individual bound sperm selection is done followed y ICSI

Group Type ACTIVE_COMPARATOR

PICSI

Intervention Type OTHER

Sperm selection using PICSI dish for selecting sperm with lower DNA fragmentation index

MACS

Semen processing is done by double layer density gradient method. The resulted pellet is labeled with annexin V microbeads followed by separation on MACS Column, the eluted fraction contains non apoptotic sperm suitable for ICSI.

Group Type ACTIVE_COMPARATOR

MACS

Intervention Type OTHER

Sperm selection using MACS for selecting sperm with lower DNA fragmentation index

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PICSI

Sperm selection using PICSI dish for selecting sperm with lower DNA fragmentation index

Intervention Type OTHER

MACS

Sperm selection using MACS for selecting sperm with lower DNA fragmentation index

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Case must have PGT-A for all of her blastocysts
* Males diagnosed with abnormal sperm DNA fragmentation index (\> 20%).
* Normo responder (\> 5 mature oocytes)
* Male will have to refrain from ejaculation no less than 1 day but no greater than 3 days prior semen specimen production on day of ICSI

Exclusion Criteria

* Leukocytospermia
* Presence of varicocele.
* Known genetic abnormality
* Use of sperm or oocyte donors
* Use of gestational carrier
* Presence of any of the endometrial factors that affect embryo implantation such as hydrosalpings, adenomyosis or previous uterine infection
* Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ganin Fertility Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eman Hasanen, BSc.

Role: PRINCIPAL_INVESTIGATOR

Ganin Fertility Center

Manar Hozayen, MSc.

Role: PRINCIPAL_INVESTIGATOR

Ganin Fertility Center

Amr Elshimy, BSc.

Role: PRINCIPAL_INVESTIGATOR

Ganin Fertility Center

Hanaa Alkhader, MBBS/MD

Role: PRINCIPAL_INVESTIGATOR

Ganin Fertility Center

Hosam Zaki, MSc, FRCOG

Role: STUDY_DIRECTOR

Ganin Fertility Center

Yara Hazem, BP

Role: PRINCIPAL_INVESTIGATOR

Ganin Fertility Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ganin Fertility Center

Cairo, Maadi, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GFC-005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.